Please see below for a selection of interesting articles on pediatric CML in peer-reviewed journals.
Latest publications include:
- Patient-reported long-term outcome following allogeneic hematopoietic stem cell transplantation in pediatric chronic myeloid leukemia
Schleicher O et al. Front Oncol. September 2022 – open access publication - Recent progress in the management of pediatric chronic myeloid leukemia – Review
Shima H and Shimada H. Int J Hematol, December 2022 (epub ahead of print) - Alterations in cellular metabolism after TKI therapy for Philadelphia chromosome-positive leukemia in children: A review
Li C et al. Front Oncol, December 2022 – open access publication - Outcomes of adolescents and young adults with chronic-phase chronic myeloid leukemia treated with tyrosine kinase inhibitors
Nishiyama-Fujita Y et al. Ann Med, December 2022 – open access publication - Prevalence of anemia at diagnosis of pediatric chronic myeloid leukemia and prognostic impact on the disease course
Delehaye F et al. Ann Hematol, November 2022 (epub ahead of print) - Current childhood chronic myeloid leukemia management under tyrosine kinase inhibitor treatment
Karadas N et al. Int J Hematol, November 2022 (epub ahead of print) - Outcome of pediatric chronic myeloid leukemia with management focusing on gene transcript levels
Al-Ghamlas I et al. Int J Pediatr Adolesc Med, September 2022 – open access publication
- Dasatinib-related pleural effusion and lymphocytosis rates are different between adult and pediatric patients with Philadelphia chromosome-positive leukemias: are age and comorbidities only to blame?
Kiliçaslan NA et al. Expert Rev Respir Med, September 2022 (epub ahead of print) - Secondary pseudotumor cerebri syndrome in a child with chronic myeloid leukemia: Report of a case and review of previous cases
Rasmussen AH et al. Pediatr Blood Cancer, September 2022 (epub ahead of print) - Management of CML in children and young adults - Review
Ford M et al. Curr Hematol Malig Res, August 2022 (epub ahead of print) - open access publication - Discontinuation of tyrosine kinase inhibitors based on BCR-ABL1 monitoring by digital droplet PCR in pediatric chronic myeloid leukemia
Kim Y et al. Front Pediatr, Jul 2022 – open access publication
Search here for more publications on pediatric CML